{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:56:21Z","timestamp":1793336181373,"version":"4.5.0"},"reference-count":164,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"vor","delay-in-days":376,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K23HL125991"],"award-info":[{"award-number":["K23HL125991"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009457","name":"American Medical Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009457","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011531","name":"University of Alabama","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011531","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jacc.2019.11.046","type":"journal-article","created":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T13:59:14Z","timestamp":1580738354000},"page":"539-555","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":108,"title":["Cardiometabolic-Based Chronic Disease, Addressing Knowledge and Clinical Practice Gaps"],"prefix":"10.1016","volume":"75","author":[{"given":"Jeffrey I.","family":"Mechanick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Farkouh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Timothy","family":"Garvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2019.11.046_bib1","doi-asserted-by":"crossref","first-page":"372","DOI":"10.4158\/EP161688.PS","article-title":"Adiposity-based chronic disease as a new diagnostic term: American Association of Clinical Endocrinologists and the American College of Endocrinology position statement","volume":"23","author":"Mechanick","year":"2017","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jacc.2019.11.046_bib2","doi-asserted-by":"crossref","first-page":"995","DOI":"10.4158\/PS-2018-0139","article-title":"Dysglycemia-based chronic disease: an American Association of Clinical Endocrinologists position statement","volume":"24","author":"Mechanick","year":"2018","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jacc.2019.11.046_bib3","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.jacc.2016.06.072","article-title":"The adipokine-cardiovascular-lifestyle network","volume":"68","author":"Mechanick","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.11.046_bib4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.gheart.2017.10.003","article-title":"Leptin, an adipokine with central importance in the global obesity problem","volume":"13","author":"Mechanick","year":"2018","journal-title":"Glob Heart"},{"key":"10.1016\/j.jacc.2019.11.046_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208953","article-title":"A\u00a0novel network-based approach for discovering dynamic metabolic biomarkers in cardiovascular disease","volume":"13","author":"Baumgartner","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jacc.2019.11.046_bib6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1039\/B912078E","article-title":"The use of network analyses for elucidating mechanisms in cardiovascular disease","volume":"6","author":"Diez","year":"2010","journal-title":"Mol Biosys"},{"key":"10.1016\/j.jacc.2019.11.046_bib7","doi-asserted-by":"crossref","first-page":"e569","DOI":"10.1016\/j.amjmed.2019.01.016","article-title":"Clinician\u2019s guide to the updated ABCs of cardiovascular disease prevention: a review part 1","volume":"132","author":"Arps","year":"2019","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2019.11.046_bib8","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jacc.2017.07.001","article-title":"Primary prevention of cardiovascular disease in diabetes mellitus","volume":"70","author":"Newman","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.11.046_bib9","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.jacc.2015.08.014","article-title":"The SI! Program for cardiovascular health promotion in early childhood: a cluster-randomized trial","volume":"66","author":"Pe\u00f1alvo","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.11.046_bib10","doi-asserted-by":"crossref","first-page":"5767864","DOI":"10.1155\/2018\/5767864","article-title":"Secondary prevention of cardiovascular diseases and application of technology for early diagnosis","volume":"2018","author":"Karunathilake","year":"2018","journal-title":"Biomed Res Internat"},{"key":"10.1016\/j.jacc.2019.11.046_bib11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3399\/bjgp19X700517","article-title":"Quaternary prevention: a balanced approach to demedicalisation","volume":"69","author":"Norma","year":"2019","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.jacc.2019.11.046_bib12","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/clc.22930","article-title":"The art of cardiovascular risk assessment","volume":"41","author":"Khambhati","year":"2018","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2019.11.046_bib13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11892-019-1178-6","article-title":"Extreme atherosclerotic cardiovascular disease (ASCVD) risk recognition","volume":"19","author":"Rosenbilt","year":"2019","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.jacc.2019.11.046_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.11.046_bib15","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/jama.2018.4242","article-title":"Nontraditional risk factors in cardiovascular disease risk assessment","volume":"320","author":"Lin","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.11.046_bib16","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.mayocp.2015.07.017","article-title":"Association of cardiorespiratory fitness with coronary heart disease in asymptomatic men","volume":"90","author":"Gander","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacc.2019.11.046_bib17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.atherosclerosis.2008.06.012","article-title":"Cardiorespiratory fitness and coronary artery calcification in young adults: the CARDIA study","volume":"203","author":"Lee","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2019.11.046_bib18","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.atherosclerosis.2015.06.020","article-title":"Low cardiorespiratory fitness and coronary artery calcification: complementary cardiovascular risk predictors in asymptomatic type 2 diabetics","volume":"241","author":"Zafrir","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2019.11.046_bib19","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.mayocp.2014.01.029","article-title":"Cardiorespiratory fitness and the paradoxical BMI-mortality risk Association in Male Veterans","volume":"89","author":"Kokkinos","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacc.2019.11.046_bib20","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.jacc.2005.07.059","article-title":"Novel metabolic risk factors for heart failure","volume":"46","author":"Ingelsson","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.11.046_bib21","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.jacc.2007.12.048","article-title":"Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study","volume":"51","author":"Bahrami","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.11.046_bib22","first-page":"637","article-title":"Risk for heart failure: the opportunity of prevention with the American Heart Association\u2019s Life\u2019s Simple 7","volume":"7","author":"Uijl","year":"2019","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2019.11.046_bib23","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1007\/s00125-019-4926-x","article-title":"Diabetes as a risk factor for heart failure in women and men: a systematic review and meta-analysis of 47 cohorts including 12 million individuals","volume":"62","author":"Ohkuma","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.jacc.2019.11.046_bib24","first-page":"917","article-title":"The heart failure overweight\/obesity survival paradox: the missing sex link","volume":"3","author":"Vest","year":"2015","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2019.11.046_bib25","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.jacc.2016.11.081","article-title":"Relationship between physical activity, body mass index, and risk of heart failure","volume":"69","author":"Pandey","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.11.046_bib26","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1161\/CIRCHEARTFAILURE.112.000054","article-title":"Physical fitness and risk for heart failure and coronary artery disease","volume":"6","author":"Berry","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2019.11.046_bib27","first-page":"347","article-title":"Fitness in young adulthood and long-term cardiac structure and function","volume":"5","author":"Pandey","year":"2017","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2019.11.046_bib28","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/ejhf.37","article-title":"Cardiorespiratory fitness and risk of heart failure: a population-based follow-up study","volume":"16","author":"Khan","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2019.11.046_bib29","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.amjcard.2013.12.030","article-title":"Joint impact of body mass index and physical capacity on mortality in patients with systolic heart failure","volume":"113","author":"Zafrir","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2019.11.046_bib30","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2015.03.002","article-title":"Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY)","volume":"65","author":"Pathak","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.11.046_bib31","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1001\/jama.2013.280521","article-title":"Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial","volume":"310","author":"Abed","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.11.046_bib32","doi-asserted-by":"crossref","first-page":"209428","DOI":"10.1155\/2013\/209428","article-title":"Mechanism of and therapeutic strategy for atrial fibrillation associated with diabetes mellitus","volume":"2013","author":"Lin","year":"2013","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.jacc.2019.11.046_bib33","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ahj.2007.10.004","article-title":"Atrial fibrillation and obesity-results of a meta-analysis","volume":"155","author":"Wanahita","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2019.11.046_bib34","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1001\/jama.292.20.2471","article-title":"Obesity and the risk of new-onset atrial fibrillation","volume":"292","author":"Wang","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.11.046_bib35","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.amjmed.2009.11.026","article-title":"Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox","volume":"123","author":"Badheka","year":"2010","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2019.11.046_bib36","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.amjcard.2016.04.036","article-title":"Impact of body mass index on the prognosis of Japanese patients with non-valvular atrial fibrillation","volume":"118","author":"Inoue","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2019.11.046_bib37","first-page":"355","article-title":"Association of body mass index with care and outcomes in patients with atrial fibrillation: results from the ORBIT-AF registry","volume":"2","author":"Pandey","year":"2016","journal-title":"J\u00a0Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2019.11.046_bib38","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1093\/eurheartj\/ehw124","article-title":"The \u201cobesity paradox\u201d in atrial fibrillation: observations from the ARISTOTLE (Apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation) trial","volume":"37","author":"Sandhu","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2019.11.046_bib39","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jacc.2015.07.003","article-title":"Physical fitness, physical activity, exercise training, and atrial fibrillation","volume":"66","author":"Thompson","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.11.046_bib40","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1161\/CIRCULATIONAHA.108.785626","article-title":"Physical activity and incidence of atrial fibrillation in older adults","volume":"118","author":"Mozaffarian","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.11.046_bib41","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1136\/heartjnl-2014-307145","article-title":"Physical activity is associated with a reduced risk of atrial fibrillation in middle-aged and elderly women","volume":"101","author":"Drca","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2019.11.046_bib42","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1161\/CIRCULATIONAHA.114.014833","article-title":"Cardiorespiratory fitness and risk of incident atrial fibrillation results from the Henry Ford exercise testing (FIT) project","volume":"131","author":"Qureshi","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.11.046_bib43","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.hrthm.2015.03.024","article-title":"Cardiorespiratory fitness and atrial fibrillation: a population-based follow-up study","volume":"12","author":"Khan","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2019.11.046_bib44","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jacc.2015.06.488","article-title":"Impact of CARDIOrespiratory FITness on arrhythmia recurrence in obese individuals with atrial fibrillation the CARDIO-FIT study","volume":"66","author":"Pathak","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.11.046_bib45","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","article-title":"2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation","volume":"74","author":"January","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.11.046_bib46","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12966-017-0639-z","article-title":"Embedding weight management into safety-net pediatric primary care: randomized controlled trial","volume":"15","author":"Wylie-Rosett","year":"2018","journal-title":"Int J Behav Nutr Phys Act"},{"key":"10.1016\/j.jacc.2019.11.046_bib47","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ahj.2017.02.020","article-title":"Rationale and design of Family-Based Approach in a Minority Community Integrating Systems\u2013Biology for Promotion of Health (FAMILIA)","volume":"187","author":"Bansilal","year":"2017","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2019.11.046_bib48","doi-asserted-by":"crossref","unstructured":"Patnode CD, Evans CV, Senger CA, et\u00a0al. Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults without known cardiovascular disease risk factors: updated systematic review for the U.S. Preventive Services Task Force. Evidence Synthesis, Number 152. AHRQ Publication No. 15-05222-EF-1,2017.","DOI":"10.1001\/jama.2017.3303"},{"key":"10.1016\/j.jacc.2019.11.046_bib49","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/S0140-6736(18)30312-X","article-title":"Origins of lifetime health around the time of conception: causes and consequences","volume":"391","author":"Fleming","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.11.046_bib50","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000485506","article-title":"Developmental origins of health span and life span: a mini-review","volume":"64","author":"Preston","year":"2018","journal-title":"Gerontol"},{"key":"10.1016\/j.jacc.2019.11.046_bib51","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2174\/1573396314666180117092010","article-title":"Pediatric markers of adult cardiovascular disease","volume":"13","author":"Olson","year":"2017","journal-title":"Curr Pediatr Rev"},{"key":"10.1016\/j.jacc.2019.11.046_bib52","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11883-018-0729-7","article-title":"Preserving cardiovascular health in young children: beginning healthier by starting earlier","volume":"20","author":"van Horn","year":"2018","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jacc.2019.11.046_bib53","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1001\/archinte.168.7.713","article-title":"Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women","volume":"168","author":"Fung","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2019.11.046_bib54","first-page":"185","article-title":"Dietary approach to stop hypertension diet and cardiovascular risk factors among 10- to 18-year-old infividuals","volume":"13","author":"Farhadnejad","year":"2018","journal-title":"Obesity"},{"key":"10.1016\/j.jacc.2019.11.046_bib55","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.diabres.2018.03.037","article-title":"The Berlin Declaration: a call to action to improve early actions related to type 2 diabetes. How can specialist care help?","volume":"139","author":"Ceriello","year":"2018","journal-title":"Diab Res Clin Pract"},{"key":"10.1016\/j.jacc.2019.11.046_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2017.10.009","article-title":"Diagnostic imaging in the management of patients with metabolic syndrome","volume":"194","author":"Kim","year":"2018","journal-title":"Translat Res"},{"key":"10.1016\/j.jacc.2019.11.046_bib57","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s00421-018-3852-9","article-title":"Effects of resistance training on MRI-derived epicardial fat volume and arterial stiffness in women with obesity: a randomized pilot study","volume":"118","author":"Fernandez-del-Valle","year":"2018","journal-title":"Eur J Appl Physiol"},{"key":"10.1016\/j.jacc.2019.11.046_bib58","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.jacc.2019.03.010","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease","volume":"74","author":"Arnett","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.11.046_bib59","doi-asserted-by":"crossref","first-page":"323","DOI":"10.21037\/atm.2018.08.03","article-title":"Beyond conventional secondary prevention in coronary artery disease\u2014what to choose in the era of CANTOS, COMPASS, FOURIER, ODYSSEY and PEGASIS-TIMI 54? A review on contemporary literature","volume":"6","author":"Kalbacher","year":"2018","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jacc.2019.11.046_bib60","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3399\/bjgp19X700517","article-title":"Quaternary prevention: a balanced approach to demedicalisation","volume":"69","author":"Norman","year":"2019","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.jacc.2019.11.046_bib61","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/13814788.2017.1422177","article-title":"Quaternary prevention: reviewing the concept","volume":"24","author":"Martins","year":"2018","journal-title":"Eur J Gen Pract"},{"key":"10.1016\/j.jacc.2019.11.046_bib62","series-title":"Lifestyle Medicine\u2013A Manual for Clinical Practice","first-page":"1","article-title":"Why lifestyle medicine?","author":"Mechanick","year":"2016"},{"key":"10.1016\/j.jacc.2019.11.046_bib63","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.11.046_bib64","series-title":"Molecular Nutrition","first-page":"63","article-title":"Molecular nutrient targeting with Mediterranean diets","author":"Russo","year":"2015"},{"key":"10.1016\/j.jacc.2019.11.046_bib65","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s10654-018-0427-3","article-title":"Evaluating Mediterranean diet and risk of chronic disease in cohort studies: an umbrella review of meta-analyses","volume":"33","author":"Galbete","year":"2018","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jacc.2019.11.046_bib66","first-page":"430","article-title":"Prevalence of metabolic syndrome and Framingham Risk Score in apparently healthy vegetarian and omnivorous men","volume":"110","author":"Navarro","year":"2018","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.jacc.2019.11.046_bib67","article-title":"Anti-inflammatory effects of a vegan diet versus the American Heart Association-recommended diet in coronary artery disease trial","volume":"7","author":"Shah","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2019.11.046_bib68","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1212914","article-title":"Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes","volume":"369","author":"Wing","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.11.046_bib69","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(98)07368-1","article-title":"Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study","volume":"353","author":"Gaede","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.11.046_bib70","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","article-title":"Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes","volume":"348","author":"Gaede","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.11.046_bib71","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(17)33102-1","article-title":"Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial","volume":"391","author":"Lean","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.11.046_bib72","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S2213-8587(19)30068-3","article-title":"Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial","volume":"7","author":"Lean","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacc.2019.11.046_bib73","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.diabres.2017.10.021","article-title":"Association between alcohol consumption and incidence of impaired insulin secretion and insulin resistance in Japanese: The Saku study","volume":"135","author":"Tatsumi","year":"2018","journal-title":"Diab Res Clin Pract"},{"key":"10.1016\/j.jacc.2019.11.046_bib74","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.pcad.2018.02.001","article-title":"Alcohol and CV health: Jekyll and Hyde J-curves","volume":"61","author":"O\u2019Keefe","year":"2018","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.jacc.2019.11.046_bib75","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0140-6736(18)31310-2","article-title":"Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"392","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.11.046_bib76","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1001\/jama.1989.03430170057028","article-title":"Physical fitness and all-cause mortality: a prospective study of healthy men and women","volume":"262","author":"Blair","year":"1989","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.11.046_bib77","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1001\/jama.2017.21649","article-title":"Fitness or fatness. Which is more important?","volume":"319","author":"Blair Kennedy","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.11.046_bib78","doi-asserted-by":"crossref","first-page":"f5577","DOI":"10.1136\/bmj.f5577","article-title":"Comparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological study","volume":"347","author":"Naci","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2019.11.046_bib79","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.maturitas.2018.02.003","article-title":"Relationships between older adults\u2019 use of time and cardio-respiratory fitness, obesity and cardio-metabolic risk: a compositional isotemporal substitution analysis","volume":"110","author":"Dumuid","year":"2018","journal-title":"Maturitas"},{"key":"10.1016\/j.jacc.2019.11.046_bib80","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/1479164114561992","article-title":"Probing SGLT2 as a therapeutic target for diabetes: basic physiology and consequences","volume":"12","author":"Gallo","year":"2015","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.jacc.2019.11.046_bib81","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.2337\/diabetes.54.12.3427","article-title":"Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes","volume":"54","author":"Rahmoune","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.jacc.2019.11.046_bib82","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.11.046_bib83","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.11.046_bib84","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Percovic","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.11.046_bib85","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.11.046_bib86","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.jacc.2018.07.071","article-title":"The changing landscape of diabetes therapy for cardiovascular risk reduction: JACC state-of-the-art review","volume":"72","author":"Newman","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.11.046_bib87","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.11.046_bib88","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/dmrr.2924","article-title":"Ketoacidosis associated with SGLT2 inhibitor treatment: analysis of FAERS data","volume":"33","author":"Blau","year":"2017","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.jacc.2019.11.046_bib89","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1172\/JCI105685","article-title":"Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic subjects","volume":"46","author":"Perley","year":"1967","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2019.11.046_bib90","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1055\/s-2004-826160","article-title":"Circulation and degradation of GIP and GLP-1","volume":"36","author":"Deacon","year":"2004","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.jacc.2019.11.046_bib91","doi-asserted-by":"crossref","first-page":"S279","DOI":"10.2337\/dc11-s231","article-title":"Long-acting glucagon-like peptide 1 receptor agonists: a review of their efficacy and tolerability","volume":"34 Suppl 2","author":"Garber","year":"2011","journal-title":"Diab Care"},{"key":"10.1016\/j.jacc.2019.11.046_bib92","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1056\/NEJMoa1901118","article-title":"Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"381","author":"Husain","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.11.046_bib93","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa1509225","article-title":"Lixisenatide in patients with type 2 diabetes and acute coronary syndrome","volume":"373","author":"Pfeffer","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.11.046_bib94","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.11.046_bib95","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.11.046_bib96","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJMoa1612917","article-title":"Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes","volume":"377","author":"Holman","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.11.046_bib97","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(18)32261-X","article-title":"Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial","volume":"392","author":"Hernandez","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.11.046_bib98","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomized placebo-controlled trial","volume":"13","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.11.046_bib99","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1161\/CIRCULATIONAHA.116.021887","article-title":"Sodium glucose cotransporter 2 inhibitors in the treatment of diabetes mellitus","volume":"134","author":"Heerspink","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.11.046_bib100","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/dom.13028","article-title":"Design and baseline characteristics of participants in the Researching cardiovascular events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide","volume":"20","author":"Gerstein","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jacc.2019.11.046_bib101","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(18)32590-X","article-title":"SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"393","author":"Zelniker","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.11.046_bib102","first-page":"S103","article-title":"Cardiovascular disease and risk management: standards of medical care in diabetes\u20132019","volume":"42 Suppl 1","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2019.11.046_bib103","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1056\/NEJMsa1213829","article-title":"Achievement of goals in U.S. diabetes care, 1999-2010","volume":"368","author":"Ali","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.11.046_bib104","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.2337\/dc18-1554","article-title":"Underuse of medications and lifestyle counselling to prevent cardiovascular disease in patients with diabetes","volume":"42","author":"Newman","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2019.11.046_bib105","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.5603\/KP.a2018.0127","article-title":"The influence of metformin and the presence of type 2 diabetes mellitus on mortality and hospitalization in patients with heart failure","volume":"76","author":"Retwinski","year":"2018","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.jacc.2019.11.046_bib106","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.diabres.2017.12.011","article-title":"Is metformin beneficial for heart failure in patients with type 2 diabetes?","volume":"136","author":"Packer","year":"2018","journal-title":"Diab Res Clin Pract"},{"key":"10.1016\/j.jacc.2019.11.046_bib107","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","article-title":"Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus","volume":"369","author":"Scirica","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.11.046_bib108","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1056\/NEJMoa1305889","article-title":"Alogliptin after acute coronary syndrome in patients with type 2 diabetes","volume":"369","author":"White","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.11.046_bib109","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1056\/NEJMoa1501352","article-title":"Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes","volume":"373","author":"Green","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.11.046_bib110","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/jama.2018.18269","article-title":"Effect of linagliptin vs placebo on major cardiovascular events in adults with type 2 diabetes and high cardiovascular and renal risk: The CARMELINA Randomized Clinical Trial","volume":"321","author":"Rosenstock","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.11.046_bib111","article-title":"Effect of linagliptin vs glimepiride on major adverse cardiovascular outcomes in patients with type 2 diabetes: The CAROLINA Randomized Clinical Trial","author":"Rosenstock","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.11.046_bib112","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.11.046_bib113","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1016\/j.jacc.2019.02.032","article-title":"Effects of icosapent ethyl on total ischemic events: from REDUCE-IT","volume":"73","author":"Bhatt","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.11.046_bib114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP161365.GL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for comprehensive medical care of patients with obesity","volume":"22 Suppl 3","author":"Garvey","year":"2016","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jacc.2019.11.046_bib115","doi-asserted-by":"crossref","first-page":"912","DOI":"10.2337\/dc13-1518","article-title":"Prevention of type 2 diabetes in subjects with prediabetes and metabolic syndrome treated with phentermine and topiramate extended-release","volume":"37","author":"Garvey","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2019.11.046_bib116","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(17)30069-7","article-title":"3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial","volume":"389","author":"le Roux","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.11.046_bib117","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1056\/NEJMoa1808721","article-title":"Cardiovascular safety of lorcaserin in overweight or obese patients","volume":"379","author":"Bohula","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.11.046_bib118","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0140-6736(15)00075-6","article-title":"Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial","volume":"386","author":"Mingrone","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.11.046_bib119","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1056\/NEJMoa1600869","article-title":"Bariatric surgery versus intensive medical therapy for diabetes: 5-year outcomes","volume":"376","author":"Schauer","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.11.046_bib120","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S2213-8587(15)00290-9","article-title":"Healthcare costs during 15 years after bariatric surgery for patients with different baseline glucose status","volume":"3","author":"Neovius","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacc.2019.11.046_bib121","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.amjcard.2006.08.017","article-title":"Reduction in predicted coronary heart disease risk after substantial weight reduction after bariatric surgery","volume":"99","author":"Vogel","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2019.11.046_bib122","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s11695-014-1407-7","article-title":"Emerging markers of atherosclerosis before and after bariatric surgery","volume":"25","author":"Domienik-Karlowicz","year":"2015","journal-title":"Obes Surg"},{"key":"10.1016\/j.jacc.2019.11.046_bib123","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.cardfail.2017.05.005","article-title":"Risk of heart failure in obese patients with and without bariatric surgery in Sweden \u2013 a registry-based study","volume":"23","author":"Persson","year":"2017","journal-title":"J\u00a0Cardiac Fail"},{"key":"10.1016\/j.jacc.2019.11.046_bib124","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/eurheartj\/ehz295","article-title":"Surgical obesity treatment and the risk of heart failure","volume":"40","author":"Jamaly","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2019.11.046_bib125","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1161\/CIRCULATIONAHA.116.025629","article-title":"Weight loss and heart failure","volume":"135","author":"Sundstrom","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.11.046_bib126","article-title":"Gastric bypass surgery produces a durable reduction in cardiovascular disease risk factors and reduces the long-term risks of congestive heart failure","volume":"6","author":"Benotti","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2019.11.046_bib127","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.soard.2018.12.030","article-title":"Impact of prior bariatric surgery on outcomes of hospitalized patients with heart failure: a population-based study","volume":"15","author":"Han","year":"2019","journal-title":"Surg Obes Rel Dis"},{"key":"10.1016\/j.jacc.2019.11.046_bib128","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.soard.2019.03.021","article-title":"Impact of bariatric surgery on heart failure mortality","volume":"15","author":"Aleassa","year":"2019","journal-title":"Surg Obes Rel Dis"},{"key":"10.1016\/j.jacc.2019.11.046_bib129","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s11695-013-1123-8","article-title":"Prevalence and predictors of atrial fibrillation among patients undergoing bariatric surgery","volume":"24","author":"Shoemaker","year":"2014","journal-title":"Obes Surg"},{"key":"10.1016\/j.jacc.2019.11.046_bib130","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1016\/j.jacc.2016.09.940","article-title":"Bariatric surgery and the risk of new-onset atrial fibrillation in Swedish obese subjects","volume":"68","author":"Jamaly","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.11.046_bib131","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.soard.2018.11.021","article-title":"Bariatric surgery reduces incidence of atrial fibrillation: a propensity score-matched analysis","volume":"15","author":"Lynch","year":"2019","journal-title":"Surg Obes Rel Dis"},{"key":"10.1016\/j.jacc.2019.11.046_bib132","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1007\/s11695-017-2923-z","article-title":"Assessment of atrial fibrillation and ventricular arrhythmia risk after bariatric surgery by P wave\/QT interval dispersion","volume":"28","author":"Yilmaz","year":"2018","journal-title":"Obes Surg"},{"key":"10.1016\/j.jacc.2019.11.046_bib133","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.amjcard.2017.06.026","article-title":"Effect of bariatric surgery on emergence department visits and hospitalizations for atrial fibrillation","volume":"120","author":"Shimada","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2019.11.046_bib134","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1093\/europace\/euz183","article-title":"Association between pre-ablation bariatric surgery and atrial fibrillation recurrence in morbidly obese patients undergoing atrial fibrillation ablation","volume":"21","author":"Donnellan","year":"2019","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2019.11.046_bib135","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jacc.2017.12.014","article-title":"Metabolic surgery: weight loss, diabetes, and beyond","volume":"17","author":"Pareek","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.11.046_bib136","author":"Mechanick","year":"2019","journal-title":"Endocr Practice"},{"key":"10.1016\/j.jacc.2019.11.046_bib137","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jama.2018.13022","article-title":"Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults","volume":"320","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.11.046_bib138","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jama.2017.7171","article-title":"Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults without cardiovascular risk factors","volume":"318","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.11.046_bib139","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1161\/01.cir.0000435173.25936.e1","article-title":"Better population health through behavior change in adults\u2013a call to action","volume":"128","author":"Spring","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.11.046_bib140","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1210\/jc.2014-3415","article-title":"Pharmacological management of obesity: an Endocrine Society clinical practice guideline","volume":"100","author":"Apovian","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2019.11.046_bib141","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.2337\/dc19-S008","article-title":"Obesity management for the treatment of type 2 diabetes: standards of medical care in diabetes\u20132019","volume":"42","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2019.11.046_bib142","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1097\/HJH.0000000000001730","volume":"36","author":"Kotsis","year":"2018","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jacc.2019.11.046_bib143","article-title":"The new 2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease","author":"Bittner","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.11.046_bib144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP15672.GLSUPPL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology\u2013clinical practice guidelines for developing a diabetes mellitus comprehensive care plan\u20132015","volume":"21 Suppl 1","author":"Handelsman","year":"2015","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jacc.2019.11.046_bib145","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4158\/CS-2018-0535","article-title":"Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm \u2013 2019 executive summary","volume":"25","author":"Garber","year":"2019","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jacc.2019.11.046_bib146","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.2337\/dci18-0033","article-title":"Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"41","author":"Davies","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2019.11.046_bib147","first-page":"S46","article-title":"Lifestyle management: standards of medical care in diabetes\u20132019","volume":"42 Suppl 1","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2019.11.046_bib148","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/dme.13603","article-title":"Diabetes UK evidence-based nutrition guidelines for the prevention and management of diabetes","volume":"35","author":"Dyson","year":"2018","journal-title":"Diabet Med"},{"key":"10.1016\/j.jacc.2019.11.046_bib149","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1210\/jc.2019-01338","article-title":"Primary prevention of ASCVD and T2D in patients at metabolic risk: an Endocrine Society clinical practice guideline","volume":"104","author":"Rosenzweig","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2019.11.046_bib150","first-page":"S34","article-title":"Comprehensive medical evaluation and assessment of comorbidities: standards of medical care in diabetes\u20132019","volume":"42 Suppl 1","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2019.11.046_bib151","doi-asserted-by":"crossref","first-page":"729","DOI":"10.4158\/PS-2019-0080","article-title":"Transcultural diabetes care in the United States \u2013 a position statement by the American Association of Clinical Endocrinologists","volume":"25","author":"Mechanick","year":"2019","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jacc.2019.11.046_bib152","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1016\/j.jacc.2017.11.004","article-title":"Systematic review for the 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults","volume":"71","author":"Reboussin","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.11.046_bib153","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.jacc.2017.07.745","article-title":"2017 focused update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk","volume":"70","author":"Lloyd-Jones","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.11.046_bib154","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP171764.APPGL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease","volume":"23 Suppl 2","author":"Jellinger","year":"2017","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jacc.2019.11.046_bib155","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1001\/jama.2018.8359","article-title":"Risk Assessment for cardiovascular disease with nontraditional risk factors","volume":"320","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.11.046_bib156","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","article-title":"2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure","volume":"70","author":"Yancy","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.11.046_bib157","first-page":"e1","article-title":"Type 2 diabetes mellitus and heart failure","volume":"139","author":"Dunlay","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.11.046_bib158","doi-asserted-by":"crossref","first-page":"e535","DOI":"10.1161\/CIR.0000000000000450","article-title":"Contributory risk and management of comorbidities of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in chronic heart failure","volume":"134","author":"Bozkurt","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.11.046_bib159","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.jacc.2017.02.001","article-title":"ACC\/AATS\/AHA\/ASE\/ASNC\/SCAI\/SCCT\/STS 2017 appropriate use criteria for coronary revascularization in patients with acute coronary syndromes","volume":"69","author":"Patel","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.11.046_bib160","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.jacc.2017.10.052","article-title":"Systematic review for the 2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"72","author":"Kusumoto","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.11.046_bib161","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1016\/j.jacc.2017.03.001","volume":"69","author":"Jessup","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.11.046_bib162","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2016.11.004","article-title":"ACC\/AHA special report: clinical practice guideline implementation strategies: a summary of systematic reviews by the NHLBI Implementation Science Work Group","volume":"69","author":"Chan","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.11.046_bib163","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/CIRCRESAHA.117.311390","article-title":"Setting the agenda for preventive cardiology","volume":"121","author":"Shapiro","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2019.11.046_bib164","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11883-018-0735-9","article-title":"Cardiovascular disease prevention: training opportunities, the challenges, and future directions","volume":"20","author":"Saeed","year":"2018","journal-title":"Curr Atheroscler Rep"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510971938622X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510971938622X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:21:47Z","timestamp":1762309307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073510971938622X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":164,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S073510971938622X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2019.11.046","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiometabolic-Based Chronic Disease, Addressing Knowledge and Clinical Practice Gaps","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2019.11.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}